home / stock / lbps / lbps short
Short Information | 4D pharma plc (NASDAQ:LBPS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 48,519 |
Total Actual Volume | 331,021 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 2,426 |
Average Short Percentage | 11.37% |
Is there a LBPS Short Squeeze or Breakout about to happen?
See the LBPS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-23-2022 | $1.56 | $1.61 | $1.61 | $1.54 | 21,703 | 5,961 | 27.47% |
06-22-2022 | $1.52 | $1.56 | $1.56 | $1.5 | 63,190 | 12,136 | 19.21% |
06-21-2022 | $2.05 | $1.76 | $2.05 | $1.69 | 121,734 | 21,675 | 17.81% |
06-16-2022 | $2.34 | $2.3499 | $2.3499 | $2.29 | 2,660 | 171 | 6.43% |
06-15-2022 | $2.44 | $2.4201 | $2.535 | $2.4201 | 2,704 | 120 | 4.44% |
06-14-2022 | $2.5 | $2.4371 | $2.65 | $2.41 | 4,794 | 266 | 5.55% |
06-13-2022 | $2.45 | $2.54 | $2.59 | $2.45 | 5,393 | 336 | 6.23% |
06-09-2022 | $2.95 | $2.7744 | $3.03 | $2.7744 | 13,395 | 123 | 0.92% |
06-08-2022 | $3 | $3.0331 | $3.15 | $2.95 | 17,475 | 610 | 3.49% |
06-06-2022 | $3.26 | $3.33 | $3.355 | $3.2453 | 7,847 | 150 | 1.91% |
06-03-2022 | $3.33 | $3.3958 | $3.3958 | $3.31 | 6,204 | 82 | 1.32% |
06-02-2022 | $3.165 | $3.35 | $3.35 | $3.165 | 4,057 | 299 | 7.37% |
06-01-2022 | $3.25 | $3.1064 | $3.25 | $3.1 | 4,600 | 608 | 13.22% |
05-31-2022 | $3.26 | $3.22 | $3.3 | $3.218 | 4,351 | 491 | 11.28% |
05-26-2022 | $3.36 | $3.37 | $3.3934 | $3.3544 | 2,882 | 200 | 6.94% |
05-25-2022 | $3.2 | $3.3 | $3.3 | $3.2 | 5,492 | 2,882 | 52.48% |
05-24-2022 | $3.23 | $3.2 | $3.23 | $3.2 | 24,487 | 425 | 1.74% |
05-23-2022 | $3.3591 | $3.31 | $3.3591 | $3.23 | 4,675 | 1,433 | 30.65% |
05-19-2022 | $3.12 | $3.17 | $3.25 | $3.1 | 5,214 | 304 | 5.83% |
05-18-2022 | $3.33 | $3.28 | $3.3644 | $3.15 | 8,164 | 247 | 3.03% |
News, Short Squeeze, Breakout and More Instantly...
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that on June 27, 2022, it received written notice from The Nasdaq Stock Market LLC (ȁ...
4D pharma plc (AIM: DDDD, Nasdaq: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, provides an update to the announcement released earlier today regarding the Company’s request for a...
- Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months - Study sites are open for patient enrolment 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) , a pharmaceutical company leading the development of Live Biotherapeutic products (LB...